Bovine Milk Oligosaccharide Study
NCT01814540 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2022-09-29
Summary
The purpose of this study is to elucidate tolerability and effectiveness in consumption of the complex indigestible sugars from dairy products called bovine milk oligosaccharides (BMO) to enrich intestinal microflora toward beneficial populations.
Conditions
- Healthy
Interventions
- DIETARY_SUPPLEMENT
-
Bovine Milk Oligosaccharide
The BMO powder will be isolated from whey streams by Hilmar Ingredients (Hilmar, California 95324). Hilmar Ingredients employs the same membrane filtration, and centrifugation processes used to purify whey protein in their commercial practice to extract and purify BMO from whey permeate. Furthermore, the same sterilization processes used on the equipment to purify whey products will be used to purify BMO. This method uses a novel high-throughput food-grade isolation protocol that leads to purification of specific BMOs with bifidogenic activity as prebiotic oligosaccharides that mimic the activities observed for Human Milk Oligosaccharides (HMO). This strategy of developing methods for their large scale fractionation allows us to obtain a final product that mimics the naturally beneficial oligosaccharides present in human milk.
- DIETARY_SUPPLEMENT
-
Placebo Glucose Polymer
Sponsors & Collaborators
-
Dairy Research Institute
collaborator OTHER -
University of California, Davis
lead OTHER
Principal Investigators
-
Daniela Barile, PhD · University of California, Davis
-
Jennifer Smilowitz, PhD · University of California, Davis
-
J. Bruce German, PhD · University of California, Davis
-
Carolyn Slupsky, PhD · University of California, Davis
-
Angela M Zivkovic, PhD · University of California, Davis
-
David A Mills, PhD · University of California, Davis
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-08-01
- Primary Completion
- 2012-11-16
- Completion
- 2021-01-22
Countries
- United States
Study Locations
More Related Trials
-
Impact of Galacto-Oligosaccharides on Adult Microbiome
NCT05207839 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Tolerability of Prebiotics on the Microbiota
NCT02628652 ·Status: COMPLETED ·Phase: NA
-
Efficacy of a 2'-Fucosylactose-based Food Supplement on the Prevention of Respiratory and Gastrointestinal Infections.
NCT07050693 ·Status: RECRUITING ·Phase: NA
-
Prebiotic Effects of Isomalto-oligosaccharide
NCT02433873 ·Status: COMPLETED ·Phase: NA
-
Effects of Fermented Dairy Products on Defecation Changes Through Gut Microbiota
NCT06862310 ·Status: COMPLETED ·Phase: NA
-
The Effect of FODMAP Content in Tube Feeding Formula on Feeding Intolerance and Nutritional Status Improvement
NCT02353689 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Probiotics on Cognition and Health
NCT02849275 ·Status: COMPLETED ·Phase: NA
-
A Bifido Bacteria to Improve Lactose Digestion and Tolerance
NCT05668468 ·Status: UNKNOWN ·Phase: NA
-
Effect of Probiotic Fermented Dairy Drinks on Intestinal Immune Response
NCT00987311 ·Status: COMPLETED ·Phase: NA
-
Infant Microbiota and Probiotic Intake Study
NCT02457338 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of Probiotics on E. Coli Gastroenteritis
NCT01225042 ·Status: COMPLETED ·Phase: NA
-
Effect of a Fermented Milk Product With Probiotics Alone or in Combination With Fibers on Constipation Symptoms
NCT02461485 ·Status: COMPLETED ·Phase: NA
-
Milk Oriented Microbiota
NCT03222804 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy
NCT04787276 ·Status: COMPLETED ·Phase: NA
-
Effect of Prebiotics on Intestinal Gas Production, Microbiota and Digestive Symptoms
NCT02618239 ·Status: COMPLETED ·Phase: NA
-
Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Lactose Solution
NCT03814668 ·Status: COMPLETED ·Phase: NA
-
Preventive Effect of Cow's Milk Fermented With Lactobacillus Paracasei CBA L74 on Common Infectious Diseases in Children
NCT05484102 ·Status: COMPLETED ·Phase: NA
-
Effects of Probiotic and Prebiotic Combinations on Premature Infants
NCT00282113 ·Status: COMPLETED ·Phase: NA
-
Effect of Bifidobacterium Lactis HN019 on Colonic Transit Time and Digestive Symptoms
NCT01171014 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Galactooligosaccharides (GOS) on the Gut Microbiota of Lactose Intolerance Individuals
NCT06915129 ·Status: COMPLETED ·Phase: NA
-
Psychophysiological Effects of Probiotic Supplementation
NCT05226520 ·Status: COMPLETED ·Phase: NA
-
A Study of Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated Diarrhea
NCT03793686 ·Status: TERMINATED ·Phase: PHASE1
-
The PRIDE Study Probiotics on Regulation and Improving Digestive hEalth
NCT01203462 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Probiotic Supplementation on Fecal Microbiota, Nutritional Status, Metabolic and Inflammatory Parameters in Patients With Type 2 Diabetes Mellitus
NCT05418179 ·Status: UNKNOWN ·Phase: NA
-
Investigation of the Ability of a Supplement to Increase Good Bacteria in the Human Intestine and Blood Sugar Levels
NCT01944904 ·Status: COMPLETED ·Phase: NA